Harrow, Inc. (HROW)
32.97
+2.11
(+6.84%)
USD |
NASDAQ |
May 21, 16:00
33.00
+0.03
(+0.09%)
After-Hours: 19:59
Harrow Research and Development Expense (TTM) : 15.36M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Eli Lilly & Co. | 14.11B |
| Esperion Therapeutics, Inc. | 44.28M |
| Theravance Biopharma, Inc. | 30.20M |
| Xeris Biopharma Holdings, Inc. | 32.20M |
| Aquestive Therapeutics, Inc. | 16.04M |